Knockdown of ITGA2 Promotes Pyroptosis in Thyroid Cancer by Regulating the DNA Damage Response
Open Access
- 18 August 2025
- journal article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (8) , 27946
Abstract
Background: The most common endocrine cancer, thyroid carcinoma (TC), has a dismal prognosis when it reaches an advanced stage. Integrin α-2 (ITGA2) has been implicated in cancer progression, influencing both DNA damage and repair mechanisms. However, it is unknown how ITGA2 influences these processes in TC. Methods: ITGA2 was identified as a key prognostic gene for TC from the Cancer Genome Atlas-thyroid carcinoma (THCA), GSE3678, GSE29265, and GSE33630 datasets. Functional assays were used to evaluate the impact of ITGA2 knockdown on cell viability, migration, apoptosis, invasion, pyroptosis (N-terminal fragment of GSDME, GSDME-N), and cytotoxicity (Lactate dehydrogenase, LDH). DNA damage markers (phosphorylated histone H2AX on serine 139 (γ-H2AX), phosphorylated ataxia telangiectasia mutated (p-ATM), phosphorylated checkpoint kinase 2 (p-CHK2)) and the level of Reactive Oxygen Species (ROS) were used to assess oxidative stress. The impact of ITGA2 inhibition on Wnt/β-catenin signaling was evaluated, and a mouse xenograft model assessed tumor growth in vivo. Results: ITGA2 was significantly overexpressed in TC. Knockdown of ITGA2 significantly reduced cell viability, migration, and invasion, while promoting pyroptosis by upregulating cleaved-poly(ADP-ribose) polymerase (PARP) and GSDME-N. ITGA2 silencing also increased LDH activity, enhanced the expression of DNA damage markers (p-ATM, γ-H2AX, p-CHK2), and increased ROS levels. Furthermore, suppression of ITGA2 activity attenuated the Wnt/β-catenin pathway by reducing the levels of MYC proto-oncogene, bHLH transcription factor (C-myc), CD44 molecule (CD44), slug, snail, β-catenin, and wingless-type MMTV integration site family, member 1 (Wnt-1). ITGA2 silencing significantly inhibited tumor growth in a mouse model. Conclusion: ITGA2 promotes TC progression by regulating the DNA damage response and inhibiting pyroptosis. Knockdown of ITGA2 increases oxidative stress, exacerbates DNA damage, and inhibits the Wnt/β-catenin pathway, indicating it may have potential as a treatment target in TC.Keywords
Funding Information
- 2024 National Traditional Chinese Medicine Comprehensive Reform Pilot Zone “Advanced Talents in Integrated Traditional Chinese and Western Medicine” Project (PDZY-2024-0708)
This publication has 40 references indexed in Scilit:
- WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunitiesGenes & Diseases, 2024
- New insights in ubiquitin-dependent Wnt receptor regulation in tumorigenesisIn Vitro Cellular & Developmental Biology - Animal, 2024
- Wnt/β-catenin-driven EMT regulation in human cancersCellular and Molecular Life Sciences, 2024
- Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaqueAtherosclerosis, 2023
- Mitochondrial pores at the crossroad between cell death and inflammatory signalingMolecular Cell, 2023
- Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathwayPhytomedicine, 2022
- ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancerCancer Letters, 2022
- qPCR and qRT-PCR analysis: Regulatory points to consider when conducting biodistribution and vector shedding studiesMolecular Therapy - Methods & Clinical Development, 2021
- Global Burden of Thyroid Cancer From 1990 to 2017JAMA Network Open, 2020
- Cell death: a review of the major forms of apoptosis, necrosis and autophagyCell Biology International, 2019